Danazol therapy in myelodysplastic syndromes
Pozzato, G.; Franzin, F.; Moretti, M.; Campanacci, L.
Haematologica 77(1): 96
1992
ISSN/ISBN: 0390-6078 PMID: 1398293 Document Number: 397976
Document emailed within 1 workday
Related Documents
Aviles, A.; García, L.D.; Romero, N.; Tripp, F.; González-Llaven, J. 1988: Treatment of myelodysplastic syndromes with danazol Archivos de Investigacion Medica 19(1): 73-77Gattermann, N.; Aul, C. 1996: Diagnosis and therapy strategy in myelodysplastic syndromes Praxis 85(3): 39-44
Giralt, M.; Rubio-Félix, D.; Sala, F.; Perdiguer, L.; Raichs, A. 1985: Clinical semiology, development and therapy of myelodysplastic syndromes Sangre 30(4-C): 705-712
Aguayo, A. 2004: The role of angiogenesis in the biology and therapy of myelodysplastic syndromes Current Hematology Reports 3(3): 184-191
Invernizzi, R.; Pecci, A.; Rossi, G.; Pelizzari, A.M.; Giusto, M.; Tinelli, C.; Ascari, E. 1997: Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes Haematologica 82(6): 660-663
Maiolo, A.T.; Cortelezzi, A.; Calori, R.; Polli, E.E. 1990: Recombinant gamma-interferon as first line therapy for high risk myelodysplastic syndromes. Italian MDS Study Group Leukemia 4(7): 480-485
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362
Dusek, J.; Bednár, B.; Dorazilová, V.; Fakan, F.; Kerekes, Z. 1990: Myelodysplastic syndromes Ceskoslovenska Patologie 26(3): 129-134
Guisasola Zulueta, M.C.; Gilsanz Fernández, C.; Tintó del Val, J.A.; García de la Fuente, A. 1986: Myelodysplastic syndromes Revista Clinica Espanola 179(4): 190-195
Strebel, U. 1988: Myelodysplastic syndromes Therapeutische Umschau. Revue Therapeutique 45(2): 100-105
Lishner, M.; Ravid, M. 1988: Myelodysplastic syndromes Harefuah 115(3-4): 73-76
Sizoo, W.; Hagenbeek, A.; Löwenberg, B.; van 't Veer, M.B.; Sintnicolaas, K. 1987: Myelodysplastic syndromes Nederlands Tijdschrift Voor Geneeskunde 131(38): 1658-1661
Carvajal Méndez, I.; García Vadillo, J.A.; Herranz Varela, A.; González Alvaro, I.; Casado Montero, F.; Castañeda Sanz, S. 1996: Polyarthritis associated with myelodysplastic syndromes Revista Clinica Espanola 196(8): 539-541
Turtureanu-Hanganu, E. 2004: The point on myelodysplastic syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 9-16
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Doll, D.C.; List, A.F. 1992: Myelodysplastic syndromes: introduction Seminars in Oncology 19(1): 1-3
Solary, E.; Fontenay, M.ël. 2010: Myeloproliferative/myelodysplastic syndromes La Revue du Praticien 60(10): 1413-1415
Neuwirtová, R.; Mociková, K.; Jelínek, J.; Musilová, J.; Havlícek, F.; Adamkov, M.; Michalová, K.; Cermák, J.; Jonásová, A.; Smolíková, A.; Straub, J.; Tothová, E.; Voglová, J.; Vozobulová, V.; Waltrová, L. 1997: Mixed myelodysplastic and myeloproliferative syndromes Casopis Lekaru Ceskych 136(23): 724-729
Sánchez Fayos, J.; Pérez Rus, G.; Outeiriño, J.; Escudero, A.; Bosch, J.M.; Calabuig, T.; Vacas, J. 1987: Myelodysplastic syndromes as preleukemic states Sangre 32(6): 715-730
Sanz, G.F.; Morel, P. 1997: Prognostic classification in myelodysplastic syndromes Pathologie-Biologie 45(8): 617-626